Latin America Anti-obesity Medication Market Size & Outlook
Related Markets
Latin America anti-obesity medication market highlights
- The Latin America anti-obesity medication market generated a revenue of USD 399.2 million in 2023.
- The market is expected to grow at a CAGR of 42.2% from 2024 to 2030.
- Country-wise, Mexico is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 399.2 million |
| Market revenue in 2030 | USD 4,688.5 million |
| Growth rate | 42.2% (CAGR from 2023 to 2030) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | |
| Key market players worldwide | Novo Nordisk A/S ADR, GlaxoSmithKline, Novartis AG ADR, Icahn Enterprises LP Depositary Units Repr Units of LP Interests, Rhythm Pharmaceuticals Inc, PureTech Health PLC |
Other key industry trends
- In terms of revenue, Latin America region accounted for 6.0% of the global anti-obesity medication market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 19,116.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anti-obesity Medication Market Scope
Anti-obesity Medication Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Gelesis | View profile | 11-50 | Boston, Massachusetts, United States, North America | http://www.gelesis.com |
| Kintai Therapeutics | View profile | 1-10 | Cambridge, Massachusetts, United States, North America | https://www.kintaitx.com/ |
| Currax Pharmaceuticals | View profile | 101-250 | Morristown, New Jersey, United States, North America | http://www.curraxpharma.com/ |
| VIVUS | View profile | 51-100 | Mountain View, California, United States, North America | http://www.vivus.com |
| Boehringer Ingelheim International GmbH | View profile | - | - | - |
| Rhythm Pharmaceuticals Inc | View profile | 226 | 222 Berkeley Street, 12th Floor, Boston, MA, United States, 02116 | http://www.rhythmtx.com |
| Icahn Enterprises LP Depositary Units Repr Units of LP Interests | View profile | 15038 | 16690 Collins Avenue, PH-1, Penthouse Suite, Sunny Isles Beach, FL, United States, 33160 | https://www.ielp.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| PureTech Health PLC | View profile | 90 | 6 Tide Street, Suite 400, Boston, MA, United States, 02210 | https://www.puretechhealth.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Latin America anti-obesity medication market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-obesity medication market will help companies and investors design strategic landscapes.
Reasons to subscribe to Latin America anti-obesity medication market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America anti-obesity medication market databook
-
Our clientele includes a mix of anti-obesity medication market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America anti-obesity medication market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America anti-obesity medication market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America Anti-obesity Medication Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
